The vaccine candidate combines Pfizer's mRNA-based quadrivalent influenza vaccine, currently in Phase III clinical trials, and a bivalent COVID-19 vaccine to p...
Clinical trials with a combination vaccine against influenza and Covid-19 have started
Fot. Thinkstock/Getty Images
Pfizer and BioNTech begin Phase I trials of an mRNA-based combination vaccine to protect against influenza and COVID-19. The vaccine dose was already given to the first participant in the US. The study is to assess the safety, tolerability and immunogenicity of the preparation.